Breast Cancer and Chemo-amennorhea (chemo-ameno)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01867229 |
Recruitment Status :
Completed
First Posted : June 3, 2013
Last Update Posted : April 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Breast Cancer | Other: observational |
Study Type : | Observational |
Actual Enrollment : | 7 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio. |
Study Start Date : | October 2011 |
Actual Primary Completion Date : | December 2013 |
Actual Study Completion Date : | December 2014 |

Group/Cohort | Intervention/treatment |
---|---|
FEC- TC
Fluorouracil- Epiadriamycine- Cyclophosphamide Taxotère-Cyclophosphamide
|
Other: observational
standard of care fore patients with non metastatic breast cancer |
- incidence and duration of the amenorrhea induced by chemotherapy [ Time Frame: 5 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
pre-menauposal breast cancer needed to be treat with chemotherapy -
Exclusion Criteria:
metastases menopausal
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01867229
Belgium | |
Clinique Saint Vincent | |
Rocourt, Liège, Belgium, 4000 | |
Cliniques Universitaires Saint-Luc | |
Brussels, Belgium, 1200 | |
Centre Hospitalier Université de Liège | |
Liège, Belgium, 4000 | |
CHR Citadelle | |
Liège, Belgium, 4000 | |
Centre hospitalier Peltzer La Tourelle | |
Verviers, Belgium, 4800 | |
France | |
Institut Claudius Renaud | |
Toulouse, France, 31059 |
Principal Investigator: | jean-Pascal Machiels | UCL-Saint Luc |
Responsible Party: | Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
ClinicalTrials.gov Identifier: | NCT01867229 |
Other Study ID Numbers: |
UCL-gyneco-001 2009/07DEC/377 ( Other Identifier: CEHF ) |
First Posted: | June 3, 2013 Key Record Dates |
Last Update Posted: | April 10, 2019 |
Last Verified: | April 2019 |
pre-menauposal neo-adjuvant or adjuvant chemotherapy no metastases |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |